Search results
Results from the WOW.Com Content Network
The National Institute for Health and Care Excellence (NICE) is an executive non-departmental public body of the Department of Health and Social Care. [ 1 ] As the national health technology assessment body of England, it is responsible for judging the cost-effectiveness of medicines and making them available on the NHS through reimbursement ...
NICE was founded in 1986 as Neptune Intelligence Computer Engineering (NICE) in Israel; later, on October 14, 1991, the Company was renamed NICE Systems Ltd with the acronym no longer in active use. Much of the early technology developed by NICE was for contact centers, financial services and business intelligence markets. [5]
The National Initiative for Cybersecurity Education (NICE) is a partnership between government, academia, and the private sector focused supporting the country's ability to address current and future cybersecurity education and workforce challenges through standards and best practices.
pseudo-blend = an abbreviation whose extra or omitted letters mean that it cannot stand as a true acronym, initialism, or portmanteau (a word formed by combining two or more words). (a) = acronym, e.g.: SARS – (a) severe acute respiratory syndrome (i) = initialism, e.g.: CD – (i) compact disc
NICEIC is one of several organisations which assesses the competence of businesses undertaking electrical work in the UK. NICEIC is one of several providers given Government approval to offer Competent Person Schemes in England and Wales to oversee electrical work within the scope of Part P of the Building Regulations.
The Nice Classification is based on a multilateral treaty administered by WIPO. This treaty, consummated on 15 June 1957 in Nice, France, is called the "Nice Agreement Concerning the International Classification of Goods and Services for the Purposes of the Registration of Marks". This Classification is commonly referred to as the "Nice ...
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
The European Society of Cardiology (ESC), [21] and National Institute for Health and Care Excellence (NICE) [23] guidelines recommend that if the patient has a CHA 2 DS 2-VASc score of 2 and above, oral anticoagulation therapy (OAC) with a vitamin K antagonist (VKA, e.g. warfarin with target INR of 2-3) or one of the direct oral anticoagulant ...